Literature DB >> 16423395

Mad1 is a transcriptional repressor of Bcl-6.

Sang C Lee1, Andrea Bottaro, Luojing Chen, Richard A Insel.   

Abstract

Bcl-6, a major regulator of B lymphocyte function that contributes to neoplastic transformation of B cells, is expressed in activated germinal center (GC) B cells and down-regulated during terminal differentiation to plasma cells. Regulation of Bcl-6 expression is incompletely characterized. Terminal B cell differentiation is associated with down-regulation of Bcl-6, activation of Blimp-1, modulation of Myc, and specifically with the up-regulation of the Mad1 and Mad4 transcription factors, which play a critical role in cell differentiation and cell cycle regulation. Because the Mad E-box consensus binding site is present in the upstream promoter of Bcl-6, we investigated whether Bcl-6 may be under control of the Mad1 transcription factor. Anti-sense Mad1 oligonucleotides abrogated the down-regulation of Bcl-6 expression that occurred during in vitro differentiation of mouse splenic B cells induced by dextran-conjugated anti-IgD Ab and IL-5. Transduction of the WEHI 231 B cell line with retroviruses expressing Mad1 down-regulated Bcl-6 expression. Expression of the 5' upstream promoter region of Bcl-6 was down-regulated by co-expression of Mad1. Last, chromatin immunoprecipitation assays with anti-Mad1 Ab demonstrated in vivo interaction of Mad1 with the Bcl-6 promoter region. The findings suggest that Mad1 is a transcriptional repressor of Bcl-6.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16423395     DOI: 10.1016/j.molimm.2005.11.017

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  5 in total

Review 1.  Common mechanisms for the regulation of B cell differentiation and transformation by the transcriptional repressor protein BCL-6.

Authors:  Saritha Kusam; Alexander Dent
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

Review 2.  B-cell lymphoma 6 and the molecular pathogenesis of diffuse large B-cell lymphoma.

Authors:  Weimin Ci; Jose M Polo; Ari Melnick
Journal:  Curr Opin Hematol       Date:  2008-07       Impact factor: 3.284

3.  Differential IL-2 expression defines developmental fates of follicular versus nonfollicular helper T cells.

Authors:  Daniel DiToro; Colleen J Winstead; Duy Pham; Steven Witte; Rakieb Andargachew; Jeffrey R Singer; C Garrett Wilson; Carlene L Zindl; Rita J Luther; Daniel J Silberger; Benjamin T Weaver; E Motunrayo Kolawole; Ryan J Martinez; Henrietta Turner; Robin D Hatton; James J Moon; Sing Sing Way; Brian D Evavold; Casey T Weaver
Journal:  Science       Date:  2018-09-14       Impact factor: 47.728

4.  miR-155 targets histone deacetylase 4 (HDAC4) and impairs transcriptional activity of B-cell lymphoma 6 (BCL6) in the Eμ-miR-155 transgenic mouse model.

Authors:  Sukhinder K Sandhu; Stefano Volinia; Stefan Costinean; Marco Galasso; Reid Neinast; Ramasamy Santhanam; Mark R Parthun; Danilo Perrotti; Guido Marcucci; Ramiro Garzon; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2012-11-19       Impact factor: 11.205

5.  Stochastic modeling of B lymphocyte terminal differentiation and its suppression by dioxin.

Authors:  Qiang Zhang; Sudin Bhattacharya; Douglas E Kline; Robert B Crawford; Rory B Conolly; Russell S Thomas; Norbert E Kaminski; Melvin E Andersen
Journal:  BMC Syst Biol       Date:  2010-04-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.